Tango Therapeutics, Inc. (TNGX) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts TNGX Hot Sheet
Join SI Premium – FREE
Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q4 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $0 versus the consensus estimate of $500.4 thousand.
For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Western Midstream prices $700M in senior notes due 2036
- CNH Industrial Capital prices $600 million in notes due 2031
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
